Abiopharma

News list

Director MAY KAREN J 🟡 adjusted position in 0 shares (1 derivative) of Solventum Corp (SOLV) Transaction Date: Mar 27, 2026 | Filing ID: 000003

Full text

News bot March 30, 2026, 11:33 p.m.
🔍 MAY KAREN J (Director)

Company: Solventum Corp (SOLV)

Report Date: 2026-03-27
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,980
- Total shares sold: 1,980
Detailed Transactions and Holdings:
- Acquired 1,980 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,544.00 | transaction_form_type: 4
- Sold 1,980 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-27 | Code: M | Expires: 2034-05-13 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
- F2: The RSUs are fully vested.